Skip to content
MARKET
NIFTY 5023842.75+127.30+0.54%
SENSEX78553.20+418.45+0.54%
NIFTY BANK51236.80-89.15-0.17%
NIFTY IT33156.40+245.60+0.75%
NIFTY PHARMA19872.35+56.20+0.28%
NIFTY AUTO23145.90-112.40-0.48%
NIFTY FMCG56234.15+178.90+0.32%
INDIA VIX13.42-0.38-2.75%
NIFTY 5023842.75+127.30+0.54%
SENSEX78553.20+418.45+0.54%
NIFTY BANK51236.80-89.15-0.17%
NIFTY IT33156.40+245.60+0.75%
NIFTY PHARMA19872.35+56.20+0.28%
NIFTY AUTO23145.90-112.40-0.48%
NIFTY FMCG56234.15+178.90+0.32%
INDIA VIX13.42-0.38-2.75%
Barakfi
⌕/

Menu

⌂Home⌕Screener⊞Compare
TermsPrivacyDisclaimerShariah
Theme
Screener
WatchlistPortfolio
Log inGet started
⌂Home⌕Screener☆Watchlist▦Portfolio
Home/Screener/GLAXO
NSEHealthcareIndia
GLAXO logo

GlaxoSmithKline Pharmaceuticals Limited

Non-Compliant
₹2,305

-1.04% today · Day ₹2,262 – ₹2,340 · NSE (public)

5/6Pass

This stock doesn't meet 1 Shariah rule. See below to understand why.

85/100
Non-Compliant

This stock doesn't meet 1 Shariah rule. See below to understand why.

Market Cap₹39,158
Revenue₹3,726
Total Debt₹10
Debt / Mcap0.03%
Non-Halal Income1.91%
SectorHealthcare
✦
Healthcare›Healthcare
▲
Mid Cap›Market cap of ₹39,158
⇅
Low Risk›Debt ratio 0.03%
Ad
Price Chart
Loading chart...
52-Week Range7% from low
₹2,218₹2,305₹3,516
52-Week Low₹2,218
52-Week High₹3,516
Prev Close₹2,329

Compliance check

Green = safe, amber = close to limit, red = over the limit

Debt level
0.03%
How much debt the company carriesLimit: 33.00%
Current debt
0.03%
Debt compared to current company valueLimit: 33.00%
Income purity
1.91%
How much income comes from non-halal sourcesLimit: 5.00%
Interest earned
1.91%
Interest income as portion of total revenueLimit: 5.00%
Money owed to company
0.75%
Outstanding receivables compared to company valueLimit: 33.00%
Cash & interest-bearing
60.81%
Cash and interest-bearing securities as a portion of total assetsLimit: 33.00%
Fixed Assets / Total Assets
6.91%
Asset composition indicatorNo hard threshold

Screening rules

Why it screened this way

✗

Cash & interest-bearing securities are 60.8% of total assets, exceeding the 33% limit under S&P.

Screening results indicate whether this stock meets specific methodology criteria. They do not constitute a fatwa or religious ruling. Consult a qualified Shariah scholar for definitive guidance. View methodology